Innate Pharma Ownership 2024 | Who Owns Innate Pharma Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

0.32%

0

Institutional Holders

9.00

Innate Pharma Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
EXCHANGE TRADED CONCEPTS, LLC0.14%0.01%113,07066,182141.15%325,642Mar 31, 2024
OPTIVER HOLDING B.V.0.09%0.00%70,56447,859210.79%203,224Mar 31, 2024
MORGAN STANLEY0.05%-44,124-2,230-4.81%127,077Mar 31, 2024
JANE STREET GROUP, LLC0.02%-14,55414,554100.00%41,916Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.01%-10,579-1,423-11.86%30,468Mar 31, 2024
BARCLAYS PLC0.00%-412--1,000Mar 31, 2024
UBS GROUP AG0.00%-2106443.84%604Mar 31, 2024
RHUMBLINE ADVISERS0.00%-205--590,000Mar 31, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.00%-200--576Mar 31, 2024

Innate Pharma's largest institutional shareholder is EXCHANGE TRADED CONCEPTS, LLC, holding 0.14% of the company's total share outstanding, currently valued at $325.64K. The top 10 institutional shareholders own together 0.32% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
EXCHANGE TRADED CONCEPTS, LLC0.14%0.01%113,07066,182141.15%325,642Mar 31, 2024
OPTIVER HOLDING B.V.0.09%0.00%70,56447,859210.79%203,224Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.01%-10,579-1,423-11.86%30,468Mar 31, 2024
MORGAN STANLEY0.05%-44,124-2,230-4.81%127,077Mar 31, 2024
JANE STREET GROUP, LLC0.02%-14,55414,554100.00%41,916Mar 31, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.00%-200--576Mar 31, 2024
RHUMBLINE ADVISERS0.00%-205--590,000Mar 31, 2024
BARCLAYS PLC0.00%-412--1,000Mar 31, 2024
UBS GROUP AG0.00%-2106443.84%604Mar 31, 2024

The largest Innate Pharma shareholder by % of total assets is EXCHANGE TRADED CONCEPTS, LLC. The company owns 113.07K shares of Innate Pharma (IPHA), representing 0.01% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
EXCHANGE TRADED CONCEPTS, LLC0.14%0.01%113,07066,182141.15%325,642Mar 31, 2024
OPTIVER HOLDING B.V.0.09%0.00%70,56447,859210.79%203,224Mar 31, 2024
JANE STREET GROUP, LLC0.02%-14,55414,554100.00%41,916Mar 31, 2024
UBS GROUP AG0.00%-2106443.84%604Mar 31, 2024
BARCLAYS PLC0.00%-412--1,000Mar 31, 2024
RHUMBLINE ADVISERS0.00%-205--590,000Mar 31, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.00%-200--576Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.01%-10,579-1,423-11.86%30,468Mar 31, 2024
MORGAN STANLEY0.05%-44,124-2,230-4.81%127,077Mar 31, 2024

As of Mar 31 2024, Innate Pharma's largest institutional buyer is EXCHANGE TRADED CONCEPTS, LLC. The company purchased 66.18K stocks of IPHA, valued at $325.64K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY0.05%-44,124-2,230-4.81%127,077Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.01%-10,579-1,423-11.86%30,468Mar 31, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.00%-200--576Mar 31, 2024
RHUMBLINE ADVISERS0.00%-205--590,000Mar 31, 2024
BARCLAYS PLC0.00%-412--1,000Mar 31, 2024
UBS GROUP AG0.00%-2106443.84%604Mar 31, 2024
JANE STREET GROUP, LLC0.02%-14,55414,554100.00%41,916Mar 31, 2024
OPTIVER HOLDING B.V.0.09%0.00%70,56447,859210.79%203,224Mar 31, 2024
EXCHANGE TRADED CONCEPTS, LLC0.14%0.01%113,07066,182141.15%325,642Mar 31, 2024

As of Mar 31 2024, Innate Pharma's biggest institutional seller is MORGAN STANLEY. The company sold -2.23K shares of IPHA, valued at $127.08K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JANE STREET GROUP, LLC0.02%-14,55414,554100.00%41,916Mar 31, 2024

Innate Pharma's largest new institutional shareholder by number of shares is JANE STREET GROUP, LLC, purchased 14.55K shares, valued at $41.92K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Innate Pharma Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
ALPS ETF Trust0.01%79,097--Feb 29, 2024
ETF Series Solutions0.00%55,1688,84219.09%Feb 29, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%22,46514,838194.55%Feb 29, 2024
iSHARES TRUST0.00%486,495--Feb 29, 2024

Innate Pharma's largest mutual fund holder by % of total assets is "ALPS ETF Trust", owning 79.10K shares, compromising 0.01% of its total assets.

Innate Pharma Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24912.50%
31 Dec, 238-
30 Sep, 238-11.11%
30 Jun, 23928.57%
31 Mar, 237-22.22%
31 Dec, 229-
30 Sep, 229-25.00%
30 Jun, 2212-
31 Mar, 2212-20.00%
31 Dec, 2115-16.67%
30 Sep, 2118-
31 Mar, 21775.00%
31 Dec, 204-33.33%
30 Sep, 206-14.29%
30 Jun, 207-30.00%
31 Mar, 2010-16.67%
31 Dec, 1912-

As of 31 Mar 24, 9 institutions are holding Innate Pharma's shares, representing an increase of 12.50% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24253,91896.97%
31 Dec, 23128,912-59.51%
30 Sep, 23318,40735.34%
30 Jun, 23235,270-38.67%
31 Mar, 23383,638-0.73%
31 Dec, 22386,442-59.07%
30 Sep, 22944,107-1.07%
30 Jun, 22954,3120.22%
31 Mar, 22952,242-31.50%
31 Dec, 211,390,12047.40%
30 Sep, 21943,114-
31 Mar, 21176,028-87.39%
31 Dec, 201,395,579-17.12%
30 Sep, 201,683,925-41.36%
30 Jun, 202,871,409-60.88%
31 Mar, 207,340,005-4.86%
31 Dec, 197,714,580-

Innate Pharma (IPHA) has 253.92K shares outstanding as of 31 Mar 24, up 96.97% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.32%1204.32%
31 Dec, 230.16%101.28%
30 Sep, 230.40%458.16%
30 Jun, 230.30%127.32%
31 Mar, 230.48%204.60%
31 Dec, 220.49%34.53%
30 Sep, 221.19%82.36%
30 Jun, 221.20%83.72%
31 Mar, 221.20%39.20%
31 Dec, 211.75%124.31%
30 Sep, 211.19%-
31 Mar, 210.22%7.13%
31 Dec, 201.77%42.25%
30 Sep, 202.05%16.81%
30 Jun, 203.49%2.90%
31 Mar, 2010.97%8.25%
31 Dec, 1911.53%-

As of 31 Mar 24, Innate Pharma is held by 0.32% institutional shareholders, representing a 1204.32% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 244100.00%
31 Dec, 232100.00%
30 Sep, 231-66.67%
30 Jun, 23350.00%
31 Mar, 232-50.00%
31 Dec, 224-
30 Sep, 224-33.33%
30 Jun, 22620.00%
31 Mar, 225-44.44%
31 Dec, 219-50.00%
30 Sep, 2118-
31 Mar, 215400.00%
31 Dec, 201-
30 Sep, 201-50.00%
30 Jun, 202-50.00%
31 Mar, 204-66.67%
31 Dec, 1912-

4 institutional shareholders have increased their position in IPHA stock as of 31 Mar 24 compared to 2 in the previous quarter (a 100.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 242-33.33%
31 Dec, 233-
30 Sep, 233-25.00%
30 Jun, 23433.33%
31 Mar, 233-25.00%
31 Dec, 224-
30 Sep, 224-
30 Jun, 224-20.00%
31 Mar, 225-
31 Dec, 215-
30 Sep, 21--
31 Mar, 212-
31 Dec, 202-
30 Sep, 202-
30 Jun, 20--100.00%
31 Mar, 205-
31 Dec, 19--

2 institutional shareholders have reduced their position in IPHA stock as of 31 Mar 24 compared to 3 in the previous quarter (a -33.33% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24912.50%253,91896.97%0.32%1204.32%4100.00%2-33.33%
31 Dec, 238-128,912-59.51%0.16%101.28%2100.00%3-
30 Sep, 238-11.11%318,40735.34%0.40%458.16%1-66.67%3-25.00%
30 Jun, 23928.57%235,270-38.67%0.30%127.32%350.00%433.33%
31 Mar, 237-22.22%383,638-0.73%0.48%204.60%2-50.00%3-25.00%
31 Dec, 229-386,442-59.07%0.49%34.53%4-4-
30 Sep, 229-25.00%944,107-1.07%1.19%82.36%4-33.33%4-
30 Jun, 2212-954,3120.22%1.20%83.72%620.00%4-20.00%
31 Mar, 2212-20.00%952,242-31.50%1.20%39.20%5-44.44%5-
31 Dec, 2115-16.67%1,390,12047.40%1.75%124.31%9-50.00%5-
30 Sep, 2118-943,114-1.19%-18---
31 Mar, 21775.00%176,028-87.39%0.22%7.13%5400.00%2-
31 Dec, 204-33.33%1,395,579-17.12%1.77%42.25%1-2-
30 Sep, 206-14.29%1,683,925-41.36%2.05%16.81%1-50.00%2-
30 Jun, 207-30.00%2,871,409-60.88%3.49%2.90%2-50.00%--100.00%
31 Mar, 2010-16.67%7,340,005-4.86%10.97%8.25%4-66.67%5-
31 Dec, 1912-7,714,580-11.53%-12---

Innate Pharma Peer Ownership


TickerCompany
ANEBAnebulo Pharmaceuticals, Inc.
CYTCyteir Therapeutics, Inc.
HCWBHCW Biologics Inc.
ELYMEliem Therapeutics, Inc.
INBXInhibrx, Inc.
IPSCCentury Therapeutics, Inc.
CSBRChampions Oncology, Inc.
STTKShattuck Labs, Inc.
DYAIDyadic International, Inc.
ADXNAddex Therapeutics Ltd
MOLNMolecular Partners AG
MNOVMediciNova, Inc.
PRDSPardes Biosciences, Inc.

IPHA Ownership FAQ


Innate Pharma is owned by institutional shareholders (0.32%), insiders (0.00%), and public (99.68%). The largest institutional shareholder of Innate Pharma is EXCHANGE TRADED CONCEPTS, LLC (0.14% of total shares) and the top mutual fund owner is ALPS ETF Trust (0.01% of total shares).

Innate Pharma's major institutional shareholders are EXCHANGE TRADED CONCEPTS, LLC, OPTIVER HOLDING B.V., MORGAN STANLEY, JANE STREET GROUP, LLC, and MILLENNIUM MANAGEMENT LLC. The top five shareholders own together 0.31% of the company's share outstanding.

As of Mar 2024, there are 9 institutional shareholders of Innate Pharma.

EXCHANGE TRADED CONCEPTS, LLC owns 113.07K shares of Innate Pharma, representing 0.14% of the company's total shares outstanding, valued at $325.64K (as of Mar 2024).

As of Mar 2024, OPTIVER HOLDING B.V holds 70.56K shares of Innate Pharma (IPHA), compromising 0.09% of the company, valued at $203.22K.

MORGAN STANLEY is the third largest holder of Innate Pharma. The company owns 44.12K of the company's shares outstanding (worth $127.08K).